HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 182 filers reported holding HERON THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $134,406 | -91.8% | 89,280 | -65.1% | 0.00% | -66.7% |
| Q4 2022 | $1,645,402 | +542.7% | 256,055 | +323.0% | 0.00% | +200.0% |
| Q3 2022 | $256,000 | +77.8% | 60,532 | +17.0% | 0.00% | 0.0% |
| Q2 2022 | $144,000 | +1.4% | 51,722 | +108.1% | 0.00% | 0.0% |
| Q1 2022 | $142,000 | -31.7% | 24,852 | +9.1% | 0.00% | 0.0% |
| Q4 2021 | $208,000 | -9.6% | 22,788 | +5.8% | 0.00% | 0.0% |
| Q3 2021 | $230,000 | -31.1% | 21,545 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $334,000 | -4.3% | 21,545 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $349,000 | -13.6% | 21,545 | +12.9% | 0.00% | 0.0% |
| Q4 2020 | $404,000 | +43.3% | 19,082 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $282,000 | +28.8% | 19,082 | +28.3% | 0.00% | 0.0% |
| Q2 2020 | $219,000 | +46.0% | 14,876 | +16.8% | 0.00% | 0.0% |
| Q1 2020 | $150,000 | -41.9% | 12,741 | +15.9% | 0.00% | 0.0% |
| Q4 2019 | $258,000 | +26.5% | 10,997 | -0.1% | 0.00% | 0.0% |
| Q3 2019 | $204,000 | – | 11,011 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |